Placebo | AZD9164 | Total | ||||
---|---|---|---|---|---|---|
GMAD, healthy subjects | n = 9 | 400 μg n = 6 | 1000 μg n = 6 | 2800 μg n = 6 | n = 27 | |
Age (yrs) | Mean | 26 | 21 | 23 | 22 | 23 |
SD | 6 | 1 | 3 | 2 | 4 | |
aBMI (kg/m2) | Mean | 23.1 | 23.4 | 21.7 | 21.6 | 22.5 |
SD | 1.7 | 1.8 | 2.2 | 1.1 | 1.8 | |
aWeight (kg) | Mean | 73.8 | 80.3 | 70.7 | 70.0 | 73.7 |
SD | 6.8 | 8.1 | 7.4 | 4.7 | 7.6 | |
JMAD, healthy subjects | n = 6 | 400 μg n = 6 | 1000 μg n = 6 | – | n = 18 | |
Age (years) | Mean | Mean 29.8 | 29.0 | 27.5 | – | 28.8 |
SD | 4.9 | 4.0 | 3.4 | – | 4.0 | |
aBMI (kg/m2) | Mean | 21.0 | 20.7 | 20.6 | – | 20.8 |
SD | 1.2 | 2.3 | 1.4 | – | 1.6 | |
aWeight (kg) | Mean | 61.3 | 63.6 | 61.4 | – | 62.1 |
SD | 4.3 | 7.7 | 5.5 | – | 5.8 | |
GMAD, COPD patients | n = 1 | – | 1000 μg n = 3 | – | n = 4 | |
Age (yrs) | Mean | 71 | – | 64 | – | 66 |
SD | NC | – | 7 | – | 6 | |
aBMI (kg/m2) | Mean | 23.0 | – | 27.8 | 26.6 | |
SD | NC | – | 4.0 | 4.0 | ||
aWeight (kg) | Mean | 77.1 | – | 73.9 | – | 74.7 |
SD | NC | – | 8.1 | – | 6.8 | |
bFEV1 (L) | Mean | 1.62 | – | 1.48 | – | 1.52 |
SD | NC | – | 0.53 | – | 0.43 | |
bFEV1 (% predicted) | Mean | 48.80 | – | 64.63 | – | 60.67 |
SD | NC | – | 17.82 | – | 16.57 | |
bFEV1/FVC (%) | Mean | 31.95 | – | 49.45 | – | 45.08 |
SD | NC | – | 5.66 | – | 9.90 | |
Smoking history (%) | Current | 1 (100) | – | 2 (67) | 3 (75) | |
Former | 0 (0) | 1 (33) | 1 (25) | |||
Years since diagnosis | Mean | 5 | 10 | 9 | ||
SD | NC | 9 | 8 |